A Multicenter, Double-blind, Crossover Design, Pilot Study to Evaluate the Effect of NVC-422 Catheter Irrigation on Urinary Catheter Patency.

Trial Profile

A Multicenter, Double-blind, Crossover Design, Pilot Study to Evaluate the Effect of NVC-422 Catheter Irrigation on Urinary Catheter Patency.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2014

At a glance

  • Drugs Auriclosene (Primary)
  • Indications Bacterial infections; Catheter infections; Urinary tract infections
  • Focus Pharmacodynamics
  • Acronyms UROvation
  • Sponsors NovaBay Pharmaceuticals
  • Most Recent Events

    • 21 May 2014 Results presented at the 109th Annual Meeting of the American Urological Association.
    • 20 May 2014 According to a NovaBay Pharmaceuticals media release, the results of this trial will be presented at the Americal Urological Association meeting.
    • 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top